Article information
Resumo
O quilotórax é o derrame pleural mais frequente no feto e no recém-nascido. O tratamento actual do quilotórax inclui várias e diferentes medidas terapêuticas pré e pós-natais.
Os autores apresentam, de forma prática e sumária, linhas de orientação para o tratamento do quilotórax no feto e no recém-nascido, incluindo a utilização das novas terapêuticas somatostatina e octreótido.
Rev Port Pneumol 2007; XIII (3): 377-381
Palavras-chave:
Quilotórax
recém-nascido
octreótido
somatostatina
Abstract
Chylothorax is the most common pleural effusion in the fetus and the neonate. Actual treatment of chylo-thorax includes many different antenatal and postnatal therapeutical approaches.
The authors present practical and summarized guidelines for the treatment of chylothorax in the fetus and the neonate, including the new therapies somatostatin and octreotide.
Rev Port Pneumol 2007; XIII (3): 377-381
Key-words:
Chylothorax
newborn
octreotide
somatostatin
Full text is only aviable in PDF
Bibliografia
[1.]
H.L.M. Straaten, L.J. Gerards, T.G. Krediet.
Chylothorax in the neonatal period.
Eur J Pediatr, 152 (1993), pp. 2.5
[2.]
L.N. Bessone, T.B. Ferguson, T.H. Burford.
Chylothorax. A collective review.
Ann Thorac Surg, 12 (1971), pp. 527-550
[3.]
J.V. Aerde, A.N. Campbell, J.A. Smyth, D. Lloyd.
Spontaneous chylothorax in newborns.
Am J Dis Child, 138 (1984), pp. 961-964
[4.]
R.F. Brodman, T.M. Zavelson, G.L. Schiebler.
Treatment of congenital chylothorax.
J Pediatr, 85 (1974), pp. 516-517
[5.]
W.S. Yancy, A. Spock.
Spontaneous neonatal pleural effusion.
J Pediatr Surg, 2 (1967), pp. 313-319
[6.]
V. Chernick, M.H. Reed.
Pneumothorax and chylotho-rax in the neonatal period.
J Pediatr, 76 (1970), pp. 624.32
[7.]
A. Greenough, N.R.C. Roberton.
Acute respiratory disease in the newborn.
3rd ed, pp. 481-607
[8.]
T.N. Hansen, A. Corbet, R.A. Ballard.
Disorders of the Chest Wall, Pleural Cavity, and Diaphragm.
8 th ed, pp. 760-763
[9.]
A. Wasmuth-pietzuch, M. Hansmann, P. Bartman, A. Heep.
Congenital chylothorax: lymphopenia and high risk of neonatal infections.
Acta Paediatr, 93 (2004), pp. 220-224
[10.]
H.J. Philippe, A. Paupe, P. Dompeyre, F. Jacquemard, R. Lenclen, F. Muller, et al.
Diagnostic antenatal et prise en charge du chylothorax congenital.
Arch Fr Pediatr, 47 (1990), pp. 737-740
[11.]
A. Hutchinson, J. Drew, V. Yu.
Nonimunologic hydrops fetalis: a review of 61 cases.
Obstet Gynecol, 59 (1982), pp. 347-352
[12.]
H. Koffler, F. Papile, R.L. Burnstein.
Congenital chylo-thorax. Two cases associated with maternal polyhydramnios.
Am J Dis Child, 132 (1978), pp. 638
[13.]
J. Doyle, B. Schmidt, V. Blanchette, Zipursky A. Hematology.
Neonatology – Pathophysiology & Management of the Newborn, 5 th ed, pp. 1045-1091
[14.]
P. Mussat, M. Dommerges, S. Parat, L. Mandelbrot, E. Gamarra, Y. Dumez, et al.
Congenital chylothorax with hydrops: postnatal care and outcome following antenatal diagnosis.
Acta Paediatr, 84 (1995), pp. 749-755
[15.]
V. Buttiker, S. Fanconi, R. Burger.
Chylothorax in children: guidelines for diagnosis and management.
Chest, 116 (1999), pp. 682-687
[17.]
P. Upadhyaya.
Pleural effusion.
Newborn Surgery, 3rd ed., pp. 187-189
[18.]
K.H. Nicolaides, M. Blott.
Pleuroamniotic shunting for decompression of fetal pleural effusions.
Obstet Gynecol, 71 (1988), pp. 798-800
[19.]
H.G. Decano Jr..
The treatment of chylothorax in children.
Surg Gynecol Obstet, 121 (1965), pp. 509-512
[20.]
S.J. Bond, P.C. Guzzetta, M.L. Snyder, S.G. Randolph.
Management of pediatric postoperative chylothorax.
Ann Thorac Surg, 56 (1993), pp. 469.72
[21.]
F. Costa.
Quilotórax.
Cirurgia Pediátrica, 2ª ed., pp. 624-630
[22.]
P.C. Rimensberger, B. Muller-Schenker, A. Kalangos, M. Beghetti.
Treatment of a persistent postoperative chylothorax with somatostatin.
Ann Thorac Surg, 66 (1998), pp. 253-254
[23.]
R.F. Kelly, S.J. Shumway.
Conservative management of postoperative chylothorax using somatostatin.
Ann Thorac Surg, 69 (2000), pp. 1944-1945
[24.]
J.I. Ulibarri, Y. Sanz, C. Fuentes, A. Mancha, M. Aramendia, S. Sanchez.
Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin.
Lancet, 336 (1990), pp. 258
[25.]
N.J. Demos, J. Kozel, J.E. Scerbo.
Somatostatin in the treatment of chylothorax.
Chest, 119 (2001), pp. 964-966
[26.]
K.M. Markham, J.L. Glover, R.J. Welsh, R.J. Lucas, P.J. Ben-dik.
Octreotide in the treatment of thoracic duct injuries.
The American Surgeon, 66 (2000), pp. 1165.7
[28.]
C.C. Roehr, A. Jung, H. Proquitté, R.R. Wauer.
Systematic review: somatostatin or octreotide as treatment options of chylothorax in young children.
Eur Resp J, 26 (2005), pp. 392s
[29.]
M. Beghetti, G. La Scala, D. Belli, P. Bugmann, A. Kalangos, C. Le Coultre.
Etiology and management of pediatric chylothorax.
J Pediatr, 136 (2000), pp. 653-658
Copyright © 2007. Sociedade Portuguesa de Pneumologia/SPP
Special content about COVID-19
- Assisted mobilisation in critical patients with COVID-19
- Two years of COVID-19: Trends in rehabilitation
- Comparison of different field tests to assess the physical capacity of post-COVID-19 patients
- New insights in circulating peptidome to differentiate mild to severe COVID-19 patients: Preliminary report
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options